Information for CJC 1295 w DAC
CJC-1295 is a synthetic analogue of growth hormone releasing hormone (GHRH) that increases plasma levels of growth hormone and insulin-like growth factor 1 (IGF-1). DAC is an additive moiety that prolongs the plasma half-life of CJC-1295.
Research Certificates of Analysis
6.98mg
Task #42379
Batch #04152024
04/23/2024
GMP Certificates of Analysis
5.2mg
Batch #PKCJCDAC5924
09/10/2024
CJC 1295 w DAC Peptide Structure
2D structure image of CID 56841945 (CJC 1295 w DAC):
PubChem Identifier: CID 56841945
URL: https://pubchem.ncbi.nlm.nih.gov/compound/56841945
Amino Acid Sequence: H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
Molecular Formula: C152H252N44O42
Molecular Weight: 3367.9 g/mol
Product Usage
This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.
